NVIDIA refocuses on its game chips
Ken Odeluga November 14, 2019 5:08 PM
The group aims to shake off Bitcoin-like volatility with rising gaming GPU sales
NVIDIA is perhaps the best-known technology company whose fate appears to be linked to the rise and fall of Bitcoin. The cryptocurrency is down more than 50% from euphoric December 2017 highs, even after rising sharply from late-2018 lows. In turn, NVIDIA shares remain some 30% lower from their October 2018 record high despite a 26% advance off lows in August.
To an extent, NVIDIA’s slump roughly in unison with Bitcoin and other cryptocurrencies makes a clear point about how much the $55bn maker of specialist chips relies on supplying processing power to coin miners. Demand in that sphere is met by the group’s OEM & IP segment. OEM & IP contributed a modest 6.5% of revenues in NVIDIA’s previous financial year. As such, with revenues down for three straight quarters, albeit exacerbated by imprudently hiked inventories, increasingly aggressive competition in other markets was more to blame. Chiefly, NVIDIA remains a leading provider of the sophisticated chips used for artificial intelligence systems that increasingly operate the world’s data centres. Yet its market share has come under increasing pressure over the last year or so. Advanced Micro Devices and Intel have been deepening inroads into NVIDIA’s server room market as well as its better-known gaming chips business. There will be a stronger focus on NVIDIA's performance in those arenas, when it reports earnings on Thursday night, than on crypto-related sales.
At the same time, the gaming chips business showed sequential growth in Q2 that could soon begin to offset tepid server rooms. The improvement puts guidance in sharp focus: Wall Street expects NVIDIA to back estimates for Q4 sales pointing to about $3.1bn, up almost 40% on the year.
Tariff and trade impacts will also be a concern, whilst a planned acquisition, a chip architecture upgrade and responses to rival AMD processors will all be of interest in the post-earnings conference calls, as well as material distractions for the group in the months ahead. However, with the shares still trading on a higher rating than rivals - almost 31 times estimated current year earnings compared to 22 times for peers - earnings and sales performance still holds key as to whether the stock extends a 55% advance so far this year or curtails it.
- Adjusted Q3 EPS forecast: $1.23, down 14%
- Q3 revenue: £2.91bn, -8.5%
- Q3 operating profit: 1.053bn, -0.5%
- Q4 revenue guidance: $3.067bn, +39%
Consensus source: Bloomberg
Disclaimer: GAIN Capital UK Limited (trading as "Forex.com") is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, Forex.com does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.
No opinion given in this material constitutes a recommendation by Forex.com or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although Forex.com is not specifically prevented from dealing before providing this material, Forex.com does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.
For further details see our full non-independent research disclaimer and quarterly summary.